Nami Yeyin

Pre-therapeutic dosimetry of normal organs and tissues of 177Lu-PSMA-617 prostate-specific membrane antigen (PSMA) inhibitor in patients with castration-resistant prostate cancer

Levent Kabasakal, Mohammad Abuqbeitah, Aslan Aygün et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2015 · 208 citations

Medicine, Oncology, Pharmacology +17

Lu-177-PSMA-617 Prostate-Specific Membrane Antigen Inhibitor Therapy in Patients with Castration-Resistant Prostate Cancer: Stability, Bio-distribution and Dosimetry

Levent Kabasakal, Türkay Toklu, Nami Yeyin et al. · Molecular Imaging and Radionuclide Therapy · 2017 · 83 citations · Full text

Medicine, Oncology, Pharmacology +17

Evaluation of radiation safety in¹⁷⁷Lu-PSMA therapy and development of outpatient treatment protocol

Mohammad Abuqbeitah, Lebriz Uslu, Özlem Yıldırım et al. · Journal of Radiological Protection · 2016 · 56 citations

Medicine, Nuclear Medicine, Oncology +17

Blood clearance and occupational exposure for 177Lu-DOTATATE compared to 177Lu-PSMA radionuclide therapy

Mohammad Abuqbeitah, Lebriz Uslu, Nami Yeyin et al. · Radiation and Environmental Biophysics · 2017 · 32 citations

Medicine, Nuclear Medicine, Radiology +16

Small Molecule, Multimodal, [18F]-PET and Fluorescence Imaging Agent Targeting Prostate-Specific Membrane Antigen: First-in-Human Study

Ömer Aras, Çetin Demirdağ, Harikrishna Kommidi et al. · Clinical Genitourinary Cancer · 2021 · 24 citations · Full text

Medicine, Molecular Medicine, Nuclear Medicine +14